Search bioRxiv⌕ Search

Biology subjects

Casiraghi, E.

Publications and source records attributed to Casiraghi, E..

2 recordsLinked to original sources

An algorithmic framework for isoform-specific functional analysis

Gene Ontology (GO) overrepresentation analysis characterizes the biological mechanisms common to sets of differentially expressed genes identified by high-throughput experiments. To date, GO overrepresentation analysis has mainly been used to evaluate differentially expressed genes, but short- and long-read RNA-seq technologies now allow increasingly accurate identification of differential alternative splicing. The function of most splice isoforms remain unknown, but if acccurate predictions could be made, overrepresentation analysis could be applied to differentially spliced isoforms to assess the functional implications of alternative splicing in RNA-seq experiments. We present isopret (Isoform Interpretation), a new paradigm for isoform function prediction based on the expectation-maximization framework. isopret leverages the relationships between sequence and functional isoform similarity to infer isoform specific functions in a highly accurate fashion. This enabled us to adapt GO overrepresentation analysis, which to date has been limited to differential gene expression, to be extended to assess overrepresentation of GO annotations in differentially spliced isoforms. An analysis of 100 RNA-seq studies including investigations of development, cancer, and common disease demonstrated that expression and splicing regulate different sets of biological functions. We make isopret predictions freely available in a desktop application that can be used to analyze differential expression and splicing in any bulk RNA-seq dataset.

bioinformatics↗

Supervised learning with word embeddings derived from PubMed captures latent knowledge about protein kinases and cancer

Inhibiting protein kinases (PKs) that cause cancers has been an important topic in cancer therapy for years. So far, almost 8% of more than 530 PKs have been targeted by FDA-approved medications and around 150 protein kinase inhibitors (PKIs) have been tested in clinical trials. We present an approach based on natural language processing and machine learning to the relations between PKs and cancers, predicting PKs whose inhibition would be efficacious to treat a certain cancer. Our approach represents PKs and cancers as semantically meaningful 100-dimensional vectors based on co-occurrence patterns in PubMed abstracts. We use information about phase I-IV trials in ClinicalTrials.gov to construct a training set for random forest classification. In historical data, associations between PKs and specific cancers could be predicted years in advance with good accuracy. Our model may be a tool to predict the relevance of inhibiting PKs with specific cancers.

bioinformatics↗